Shortly before the partial government shutdown, the Centers for Disease Control and Prevention (CDC) issued a wakeup call – in the form of a report – on the increasingly alarming growth of antibiotic resistance in the United States, with implications for healthcare providers.
NAHC Report 2011. Copyright National Association for Home Care and Hospice, Inc (www.nahc.org) .— Reprinted with permission
NAHC Report Article
Monday, June 27, 2011
________________________________________ NAHC To Sponsor Study on Best Practices Home Care Agencies Urged To Submit Questions The National Association for Home Care and Hospice, the co-sponsor on what promises to be the largest study in the history of home care on best practices for reducing avoidable hospitalizations, is inviting and encouraging agency leaders and staff from home care agencies to go on line and make recommendations for questions that should be asked in the National Study of best practices.
Health Care Professionals Can Help Protect Patients, CDC Stresses The Centers for Disease Control and Prevention (CDC) has updated its guidance for seasonal influenza practices in health care settings. In this guidance, CDC continues to emphasize the importance of a comprehensive influenza prevention strategy that can be applied across the entire spectrum of health care settings.
NAHC Report 2010. Copyright National Association for Home Care and Hospice, Inc (www.nahc.org) .— Reprinted with permission.
Jeffrey E. Shuren, MD, acting director of the Food and Drug Administration's (FDA) Center for Devices and Radiological Health, issued a letter Nov. 13 concerning dangers associated with negative wound therapy and important considerations for health care practitioners using negative pressure wound therapy systems for their patients. Negative pressure wound therapy, also known as wound vacs, are commonly used with home health patients.
NAHC Report 2009. Copyright National Association for Home Care and Hospice, Inc (www.nahc.org) .— Reprinted with permission
Clinicians Advised to Halt Use of Propofol from Tainted Lots
The Centers for Disease Control and Prevention (CDC) has been investigating recent cases of febrile reactions among patients undergoing endoscopy in the United States. This investigation has revealed that all of the case-patients received the anesthetic propofol from 100 mL vials manufactured by Teva Pharmaceutical Industries. Testing done by the Food and Drug Administration (FDA) has found that two lots of this product that were in use in facilities reporting reactions were positive for elevated levels of endotoxin. The lots are 31305429B and 31305430B. Teva Pharmaceuticals is initiating a voluntary recall for these lots, and clinicians are adv ised to immediately
stop using these lots of Teva Pharmaceuticals propofol. CDC, FDA and Teva Pharmaceutical Industries are continuing to investigate this issue.